Celldex Therapeutics (CLDX) - News Mentions

Sign up to add (CLDX) to your portfolio and access more historical data.

10%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 0 100%
Gilead Sciences
Gilead Sciences
GILD		 0 0%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 100%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
HC Wainwright Reiterates Buy Rating for Celldex Therapeutics (NASDAQ:CLDX)
November 22
What is HC Wainwright’s Estimate for CLDX FY2024 Earnings?
November 13
Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Average Rating of “Moderate Buy” by Brokerages
November 12
Celldex Therapeutics to Present at Upcoming Investor Conferences
November 11
Celldex Therapeutics Third Quarter 2024 Earnings: Beats Expectations
November 7
Celldex Therapeutics (CLDX) Reports Q3 Loss, Tops Revenue Estimates
November 6
Celldex Therapeutics : Reports Third Quarter 2024 Financial Results and Provides Corporate Update Form 8 K
November 6
Celldex Therapeutics' Strong Cash Runway Supports Barzolvolimab's Path To Market
November 3
Celldex Therapeutics (NASDAQ:CLDX) Shares Down 6% - Here's What Happened
October 29
Celldex Therapeutics' (CLDX) Buy Rating Reiterated at HC Wainwright
October 28
Celldex Therapeutics (NASDAQ:CLDX) pulls back 6.1% this week, but still delivers shareholders fantastic 57% CAGR over 5 years
October 27
Analyst Expectations For Celldex Therapeutics's Future
October 27
Celldex Therapeutics, Inc. (NASDAQ:CLDX) Stock Position Lifted by Novo Holdings A S
October 27
Celldex Therapeutics (CLDX) Reports Positive Results in Chronic Inducible Urticaria Study
October 25
Celldex Therapeutics (CLDX): A Top Small-Cap Growth Stock with Promising Clinical Results
October 22
AQR Capital Management LLC Buys 1,504 Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX)
October 17

Month over Month

Est. daily news mentions.

Oct 2024 0
Sep 2024 0
Aug 2024 0
Jul 2024 0
Jun 2024 0

How often is Celldex Therapeutics mentioned in the news?

Celldex Therapeutics was mentioned an estimated 1 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Celldex Therapeutics performing compared to its industry peers?

Celldex Therapeutics underperforms its industry peers when it comes to News Mentions, ranking in the 33rd percentile.

Has there been an increase or decrease in news mentions of Celldex Therapeutics in the last month?

There has been no significant change in the number of news mentions for Celldex Therapeutics' compared to the last month.

Why is it important to track news mentions for Celldex Therapeutics?

By monitoring mentions in the news for Celldex Therapeutics, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Celldex Therapeutics, ultimately improving their investment strategies.

Sign up and get more insights on Celldex Therapeutics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact